U.S. Capital Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.14M | Buy |
|
|||||
|
2025
Q2 | $3.31M | Buy |
|
|||||
|
2025
Q1 | $609K | Buy |
|
|||||
|
2024
Q4 | $596K | Sell |
|
|||||
|
2024
Q3 | $834K | Sell |
|
|||||
|
2024
Q2 | $2.6M | Sell |
|
|||||
|
2024
Q1 | $2.73M | Buy |
|
|||||
|
2023
Q4 | $1.6M | Buy |
|
|||||
|
2023
Q3 | $1.39M | Sell |
|
|||||
|
2023
Q2 | $1.36M | Sell |
|
|||||
|
2023
Q1 | $1.38M | Sell |
|
|||||
|
2022
Q4 | $1.2M | Buy |
|
|||||
|
2022
Q3 | $809K | Buy |
|
|||||
|
2022
Q2 | $896K | Buy |
|
|||||
|
2022
Q1 | $854K | Sell |
|
|||||
|
2021
Q4 | $869K | Buy |
|
|||||
|
2021
Q3 | $702K | Buy |
|